ID APR_HUMAN Reviewed; 54 AA. AC Q13794; B2R4T7; DT 30-MAY-2000, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1996, sequence version 1. DT 07-JUL-2009, entry version 59. DE RecName: Full=Phorbol-12-myristate-13-acetate-induced protein 1; DE Short=PMA-induced protein 1; DE AltName: Full=Immediate-early-response protein APR; DE AltName: Full=NOXA; GN Name=PMAIP1; Synonyms=NOXA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=90376412; PubMed=2398525; RA Hijikata M., Kato N., Sato T., Kagami Y., Shimotohno K.; RT "Molecular cloning and characterization of a cDNA for a novel phorbol- RT 12-myristate-13-acetate-responsive gene that is highly expressed in an RT adult T-cell leukemia cell line."; RL J. Virol. 64:4632-4639(1990). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., RA Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., RA Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., RA Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., RA Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., RA Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., RA Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., RA Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., RA Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., RA Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., RA Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., RA Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., RA Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., RA Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., RA Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., RA Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., RA Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., RA Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., RA Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., RA Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Ovary; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP FUNCTION, AND INDUCTION. RX MEDLINE=20268001; PubMed=10807576; DOI=10.1126/science.288.5468.1053; RA Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., RA Tokino T., Taniguchi T., Tanaka N.; RT "Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of RT p53-induced apoptosis."; RL Science 288:1053-1058(2000). RN [5] RP FUNCTION, INDUCTION, SUBCELLULAR LOCATION, INTERACTION WITH BAX, AND RP MUTAGENESIS OF LEU-29. RX PubMed=15705586; DOI=10.1074/jbc.M412630200; RA Sun Y., Leaman D.W.; RT "Involvement of Noxa in cellular apoptotic responses to interferon, RT double-stranded RNA, and virus infection."; RL J. Biol. Chem. 280:15561-15568(2005). RN [6] RP FUNCTION, MASS SPECTROMETRY, MUTAGENESIS OF PHE-32 AND LYS-35, AND RP INTERACTION WITH MCL1. RX PubMed=15694340; DOI=10.1016/j.molcel.2004.12.030; RA Chen L., Willis S.N., Wei A., Smith B.J., Fletcher J.I., Hinds M.G., RA Colman P.M., Day C.L., Adams J.M., Huang D.C.S.; RT "Differential targeting of prosurvival Bcl-2 proteins by their BH3- RT only ligands allows complementary apoptotic function."; RL Mol. Cell 17:393-403(2005). RN [7] RP FUNCTION, INTERACTION WITH MCL1, INDUCTION, AND SUBCELLULAR LOCATION. RX PubMed=17374615; DOI=10.1074/jbc.M611186200; RA Han J., Goldstein L.A., Hou W., Rabinowich H.; RT "Functional linkage between NOXA and Bim in mitochondrial apoptotic RT events."; RL J. Biol. Chem. 282:16223-16231(2007). RN [8] RP FUNCTION, MUTAGENESIS OF LEU-29; PHE-32 AND LEU-36, AND INTERACTION RP WITH MCL1. RX PubMed=17389404; DOI=10.1073/pnas.0701297104; RA Czabotar P.E., Lee E.F., van Delft M.F., Day C.L., Smith B.J., RA Huang D.C.S., Fairlie W.D., Hinds M.G., Colman P.M.; RT "Structural insights into the degradation of Mcl-1 induced by BH3 RT domains."; RL Proc. Natl. Acad. Sci. U.S.A. 104:6217-6222(2007). CC -!- FUNCTION: Promotes activation of caspases and apoptosis. Promotes CC mitochondrial membrane changes and efflux of apoptogenic proteins CC from the mitochondria. Contributes to p53-dependent apoptosis CC after radiation exposure. Promotes proteasomal degradation of CC MCL1. Competes with BAK1 for binding to MCL1 and can displace BAK1 CC from its binding site on MCL1 (By similarity). Competes with CC BIM/BCL2L11 for binding to MCL1 and can displace BIM/BCL2L11 from CC its binding site on MCL1. CC -!- SUBUNIT: Interacts with MCL1 and BAX. CC -!- INTERACTION: CC Q07440:Bcl2a1 (xeno); NbExp=1; IntAct=EBI-707392, EBI-707754; CC Q07820:MCL1; NbExp=1; IntAct=EBI-707392, EBI-1003422; CC P97287:Mcl1 (xeno); NbExp=1; IntAct=EBI-707392, EBI-707292; CC -!- SUBCELLULAR LOCATION: Mitochondrion. CC -!- TISSUE SPECIFICITY: Highly expressed in adult T-cell leukemia cell CC line. CC -!- INDUCTION: Up-regulated by p53, phorbol esters, double-stranded CC RNA, interferon-beta, and virus. CC -!- DOMAIN: The BH3 motif is essential for pro-apoptotic activity. CC -!- SIMILARITY: Belongs to the PMAIP1 family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; D90070; BAA14111.1; -; mRNA. DR EMBL; AK311943; BAG34884.1; -; mRNA. DR EMBL; BC013120; AAH13120.1; -; mRNA. DR IPI; IPI00015177; -. DR PIR; I37018; I37018. DR RefSeq; NP_066950.1; -. DR UniGene; Hs.96; -. DR IntAct; Q13794; 7. DR Ensembl; ENSG00000141682; Homo sapiens. DR GeneID; 5366; -. DR KEGG; hsa:5366; -. DR UCSC; uc002lic.2; human. DR GeneCards; GC18P055718; -. DR H-InvDB; HIX0014485; -. DR HGNC; HGNC:9108; PMAIP1. DR MIM; 604959; gene. DR PharmGKB; PA33434; -. DR HOVERGEN; Q13794; -. DR Reactome; REACT_578; Apoptosis. DR NextBio; 20800; -. DR ArrayExpress; Q13794; -. DR Bgee; Q13794; -. DR CleanEx; HS_PMAIP1; -. DR GermOnline; ENSG00000141682; Homo sapiens. DR GO; GO:0005739; C:mitochondrion; IDA:HGNC. DR GO; GO:0005515; F:protein binding; IPI:IntAct. DR GO; GO:0006919; P:activation of caspase activity; IDA:HGNC. DR GO; GO:0006921; P:cell structure disassembly during apoptosis; IDA:HGNC. DR GO; GO:0006917; P:induction of apoptosis; IDA:HGNC. DR GO; GO:0001836; P:release of cytochrome c from mitochondria; IDA:HGNC. DR GO; GO:0043331; P:response to dsRNA; IDA:HGNC. DR GO; GO:0006926; P:virus-infected cell apoptosis; IDA:HGNC. DR InterPro; IPR000712; Bcl2_BH. DR PROSITE; PS01259; BH3; FALSE_NEG. PE 1: Evidence at protein level; KW Apoptosis; Complete proteome; Mitochondrion. FT CHAIN 1 54 Phorbol-12-myristate-13-acetate-induced FT protein 1. FT /FTId=PRO_0000064644. FT REGION 41 50 Required for mitochondrial location. FT MOTIF 29 37 BH3. FT MUTAGEN 29 29 L->A: Reduced interaction with BAX. FT MUTAGEN 29 29 L->E: Loss of interaction with MCL1 and FT of increased MCL1 degradation; when FT associated with E-32 and E-32. FT MUTAGEN 32 32 F->E: Loss of interaction with MCL1 and FT of increased MCL1 degradation; when FT associated with E-29 and E-36. FT MUTAGEN 32 32 F->I: Alters specificity of protein FT interaction and enhances pro-apoptotic FT activity; when associated with E-35. FT MUTAGEN 35 35 K->E: Alters specificity of protein FT interaction and enhances pro-apoptotic FT activity; when associated with I-32. FT MUTAGEN 36 36 L->E: Loss of interaction with MCL1 and FT of increased MCL1 degradation; when FT associated with E-29 and E-32. SQ SEQUENCE 54 AA; 6030 MW; 291A142B27167E70 CRC64; MPGKKARKNA QPSPARAPAE LEVECATQLR RFGDKLNFRQ KLLNLISKLF CSGT //